Shanghai Xiao Fang Pharmaceutical Co.,Ltd.

SHSE:603207 Stock Report

Market Cap: CN¥4.4b

Shanghai Xiao Fang PharmaceuticalLtd Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 603207?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,971,0603.11%
General Public47,028,94029.4%
Private Companies108,000,00067.5%

Dilution of Shares: 603207 only recently listed within the past 12 months


Top Shareholders

Top 7 shareholders own 70.61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
58.8%
Winguide Far East Limited
94,080,000CN¥2.6b0%no data
3.6%
Jiaxing Youjia Enterprise Management Partnership (Limited Partnership)
5,760,000CN¥157.4m0%no data
3.6%
Jiaxing Biyu Enterprise Management Partnership (Limited Partnership)
5,760,000CN¥157.4m0%no data
1.5%
Laobaixing Pharmaceutical Group Co., Ltd.
2,400,000CN¥65.6m0%no data
1.5%
Guosen Capital Co., Ltd.
2,400,000CN¥65.6m0%15.41%
1.5%
Shandong New Era Equity Investment Fund Management Co., Ltd.
2,400,000CN¥65.6m0%no data
0.11%
Guosen Securities Co., Ltd., Asset Management Arm
171,060CN¥4.7m0%0.06%